Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
$0.56−0.04 (-7.07%)
Close on Nov 17, 2026Market cap $1.45MP/E –Yield –
Calidi Biotherapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Calidi Biotherapeutics's ebitda for the twelve months ending Jun 30, 2026 was -$16.14M. For fiscal 2025 it was -$18.59M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.59M | – |
| FY2024 | Dec 31, 2024 | -$20.24M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.71M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.76M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.04M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.62M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.67M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.63M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.84M | – |
See a number that looks wrong?